T1	Participants 85 115	very-low-birth-weight infants.
T2	Participants 561 573	multicenter,
#1	AnnotatorNotes T2	participants are from multicenter
T3	Participants 602 794	2416 infants were stratified according to birth weight (501 to 1000 g and 1001 to 1500 g) and randomly assigned to an intravenous immune globulin group (n = 1204) or a control group (n = 1212)
